References
- Sencer D, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg. Infect. Dis.12, 29–33 (2006).
- Parkman PD, Hopps HE, Rastogi SC, Meyer HM Jr. Summary of influenza virus vaccine trials in adults. J. Infect. Dis.136, S722–S730 (1977).
- Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N. Eng. J. Med.354, 1343–1351 (2006).
- Nicholson KG, Colegate AE, Podda A et al. Safety and antigenicity of nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet357, 1937–1943 (2001).
- Atmar R, Keitel WA, Patel SM et al. Safety and immunogenicity of non-adjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin. Infect. Dis.43, 1135–1142 (2006).
- Leroux-Roels I, Borkowski A, Vanwolleghem T et al. Antigen sparing and cross reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: randomized controlled trial. Lancet370, 580–589 (2007).
- Lin J, Zhang J, Dong X et al. Safety and immunogenicity of an inactivated adjuvanted whole-virus influenza (H5N1) vaccine: Phase I controlled trial. Lancet368, 991–997 (2006).
- Ehrlich H, Müller M, Oh HM et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N. Eng. J. Med.358, 2573–2583 (2008).
- Galli G, Hancock K, Hoschler K et al. Fast rise of broadly cross reactive antibodies after boosting long lived memory B cells primed by an MF59-adjuvanted vaccine. Proc. Natl Acad. Sci. USA106, 7962–7967 (2009).
- Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M. An epidemiologic and clinical evaluation of Guillain–Barré syndrome reported in association with the administration of swine influenza vaccines. Am. J. Epidemiol.119, 841–879 (1984).
- Haber P, DeStefano F, Angulo FJ et al. Guillain-Barré syndrome following influenza vaccination. JAMA292, 2478–2481 (2004).
Website
- WHO. Influenza A (H1N1) – update 41 (2009) www.who.int/csr/don/2009_05_29/en/index.html